599183-32-1 Usage
Uses
Used in Pharmaceutical Research and Development:
1H-Indazole-1-carboxylic acid, 5-amino-3-methyl-, 1,1-dimethylethyl ester is used as a compound in pharmaceutical research and development for its potential applications in the synthesis of novel drug candidates. Its unique structural features and chemical properties may contribute to the development of new therapeutic agents.
Used in Analytical Testing and Characterization:
1H-Indazole-1-carboxylic acid, 5-amino-3-methyl-, 1,1-dimethylethyl ester is also used as a reference material for analytical testing and characterization in pharmaceutical research. Its distinct chemical properties make it a valuable tool for evaluating and comparing the properties of other compounds in the development process.
Check Digit Verification of cas no
The CAS Registry Mumber 599183-32-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,9,1,8 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 599183-32:
(8*5)+(7*9)+(6*9)+(5*1)+(4*8)+(3*3)+(2*3)+(1*2)=211
211 % 10 = 1
So 599183-32-1 is a valid CAS Registry Number.
599183-32-1Relevant articles and documents
NOVEL HYDRAZONE DERIVATIVE WITH ARYL OR HETEROARYL GROUP SUBSTITUTED AT TERMINAL AMINE GROUP THEREOF AND USE THEREOF
-
Paragraph 0136-0137; 0208-0209, (2021/11/04)
The present invention relates to novel hydrazone derivatives in which a terminal amine group is substituted with an aryl group or a heteroaryl group, and uses thereof.
Novel hydrazone derivatives comprising aryl or heteroaryl group substituted at terminal amine and use thereof
-
Paragraph 0639; 0645; 0646; 0984; 0990-0992, (2020/08/28)
The present invention relates to novel hydrazone derivatives with an aryl or heteroaryl group substituted at a terminal amine group thereof and a use thereof.
NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS
-
Page/Page column 23, (2010/12/29)
This disclosure relates to compounds of formula (I): wherein R1, R2, R3, R4, E, and n1 are as defined in the disclosure, to compositions containing them, to processes for preparing them, and the use t